Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain

NCT04666714 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuropathic Pain

Interventions

DRUG: Praga formulation
OTHER: Placebo pregabalin 75mg
OTHER: Placebo Pregabalin 150mg
DRUG: Pregabalin 75mg
DRUG: Pregabalin 150mg
OTHER: Placebo Praga formulation

Sponsor

EMS